{"created":"2023-07-27T06:56:25.372380+00:00","id":53264,"links":{},"metadata":{"_buckets":{"deposit":"0d774b5b-bef4-487a-b497-c5270d29cb21"},"_deposit":{"created_by":18,"id":"53264","owners":[18],"pid":{"revision_id":0,"type":"depid","value":"53264"},"status":"published"},"_oai":{"id":"oai:kanazawa-u.repo.nii.ac.jp:00053264","sets":["2812:2813:2821"]},"author_link":["11684","81107"],"item_9_biblio_info_8":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2013-05-23","bibliographicIssueDateType":"Issued"},"bibliographicPageStart":"4p.","bibliographicVolumeNumber":"2010 – 2012","bibliographic_titles":[{"bibliographic_title":"平成24(2012)年度 科学研究費補助金 基盤研究(C) 研究成果報告書"},{"bibliographic_title":"2012 Fiscal Year Final Research Report","bibliographic_titleLang":"en"}]}]},"item_9_creator_33":{"attribute_name":"著者別表示","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{}],"nameIdentifiers":[{},{},{}]}]},"item_9_description_21":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"大槽内に留置したマイクロカテーテルから、クモ膜下出血発症24時間から72 時間以内に組織プラスミノーゲンアクチベーターを注入する髄腔内血栓溶解療法が脳血管攣縮予防法となり得る。くも膜下出血後の脳血管攣縮治療薬が血管に到達するためには、まず、血栓溶解剤でくも膜下腔の血腫を溶解させることが必要であり 、脳血管攣縮治療法としては、血管拡張剤である塩酸ニトロプルシドが最有力であることを動物実験で確認した。","subitem_description_type":"Abstract"},{"subitem_description":"Intrathecal infusion of tissure plasminogen activator between 24 and 72 hours after subarachnoid hemorrhage can prevent the angiospasm. Clearance of subarachnoid hemorrhage by thrombolytic agent is necessary for the vasodilator agent reaching the vascular wall. I t is also confirmed that vasodilator agent of SNP is most useful for the therapy of the angiospasm.","subitem_description_type":"Abstract"}]},"item_9_description_22":{"attribute_name":"内容記述","attribute_value_mlt":[{"subitem_description":"研究課題/領域番号:22591580, 研究期間(年度):2010 – 2012","subitem_description_type":"Other"},{"subitem_description":"出典：研究課題「血栓溶解剤と血管拡張剤の大槽内注入による脳血管攣縮予防法と治療法」課題番号22591580\n（KAKEN：科学研究費助成事業データベース（国立情報学研究所）） \n（https://kaken.nii.ac.jp/ja/report/KAKENHI-PROJECT-22591580/22591580seika/）を加工して作成","subitem_description_type":"Other"}]},"item_9_description_5":{"attribute_name":"提供者所属","attribute_value_mlt":[{"subitem_description":"金沢大学医薬保健研究域医学系","subitem_description_type":"Other"}]},"item_9_identifier_registration":{"attribute_name":"ID登録","attribute_value_mlt":[{"subitem_identifier_reg_text":"10.24517/00059548","subitem_identifier_reg_type":"JaLC"}]},"item_9_relation_28":{"attribute_name":"関連URI","attribute_value_mlt":[{"subitem_relation_name":[{"subitem_relation_name_text":"https://kaken.nii.ac.jp/ja/search/?kw=40253752"}],"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://kaken.nii.ac.jp/ja/search/?kw=40253752","subitem_relation_type_select":"URI"}},{"subitem_relation_name":[{"subitem_relation_name_text":"https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-22591580/"}],"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-22591580/","subitem_relation_type_select":"URI"}},{"subitem_relation_name":[{"subitem_relation_name_text":"https://kaken.nii.ac.jp/ja/report/KAKENHI-PROJECT-22591580/22591580seika/"}],"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://kaken.nii.ac.jp/ja/report/KAKENHI-PROJECT-22591580/22591580seika/","subitem_relation_type_select":"URI"}}]},"item_9_version_type_25":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_ab4af688f83e57aa","subitem_version_type":"AM"}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2020-10-05"}],"displaytype":"detail","filename":"ME-PR-HAMADA-J-kaken 2013-4p.pdf","filesize":[{"value":"703.6 kB"}],"format":"application/pdf","licensetype":"license_11","mimetype":"application/pdf","url":{"label":"ME-PR-HAMADA-J-kaken 2013-4p.pdf","url":"https://kanazawa-u.repo.nii.ac.jp/record/53264/files/ME-PR-HAMADA-J-kaken 2013-4p.pdf"},"version_id":"a3c6e496-937f-4a0a-8ea0-3a24cc5a583b"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"research report","resourceuri":"http://purl.org/coar/resource_type/c_18ws"}]},"item_title":"血栓溶解剤と血管拡張剤の大槽内注入による脳血管攣縮予防法と治療法","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"血栓溶解剤と血管拡張剤の大槽内注入による脳血管攣縮予防法と治療法"},{"subitem_title":"Intrathecal infusion of thrombolytic agent and/or vasodilator from cisterna magna for prevention and therapy of angiospasm","subitem_title_language":"en"}]},"item_type_id":"9","owner":"18","path":["2821"],"pubdate":{"attribute_name":"公開日","attribute_value":"2020-10-05"},"publish_date":"2020-10-05","publish_status":"0","recid":"53264","relation_version_is_last":true,"title":["血栓溶解剤と血管拡張剤の大槽内注入による脳血管攣縮予防法と治療法"],"weko_creator_id":"18","weko_shared_id":-1},"updated":"2023-07-27T12:00:59.655150+00:00"}